Related Experiment Videos

Human immunodeficiency virus-negative multicentric Castleman's disease coexistent with Kaposi's sarcoma on 18F-FDG

Jae Pil Hwang1, Jiyoon Kim2, Jung Mi Park1

  • 1Department of Nuclear Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Gyeonggi 420-767, Republic of Korea.

Insights

This case study highlights a rare instance of human immunodeficiency virus (HIV)-negative multicentric Castleman's disease coexisting with Kaposi's sarcoma. Treatment with chemotherapy led to near-complete remission of the hypermetabolic lesions.

Area of Science:

  • Oncology
  • Infectious Diseases
  • Radiology

Background:

  • Multicentric Castleman's disease (MCD) and Kaposi's sarcoma (KS) are often associated with human immunodeficiency virus (HIV) infection.
  • However, a significant proportion (40-50%) of MCD and KS cases occur in HIV-negative individuals.
  • This underscores the importance of considering these diagnoses in HIV-negative patients presenting with relevant symptoms.

Purpose of the Study:

  • To report a case of coexisting HIV-negative multicentric Castleman's disease and Kaposi's sarcoma.
  • To illustrate the diagnostic utility of advanced imaging techniques in such rare conditions.
  • To present the treatment outcome and response to chemotherapy.

Main Methods:

  • A 61-year-old male patient presented with palpable masses.
  • Diagnostic workup included contrast-enhanced computed tomography (CT) and fluorine-18-fluorodeoxyglucose positron emission tomography (18F-FDG PET)/CT.
  • Excisional biopsy with immunohistochemical analysis confirmed the diagnosis.

Main Results:

  • Imaging revealed multiple enlarged, hypermetabolic lymph nodes across cervical, thoracic, and abdominopelvic regions.
  • Histopathology confirmed coexisting HIV-negative multicentric Castleman's disease and Kaposi's sarcoma.
  • Following steroid therapy and four cycles of chemotherapy, follow-up 18F-FDG PET/CT showed near-complete remission of malignant lesions.

Conclusions:

  • This case demonstrates the possibility of co-occurrence of HIV-negative MCD and KS.
  • Integrated imaging like 18F-FDG PET/CT is crucial for accurate diagnosis and staging.
  • Chemotherapy can be an effective treatment modality for this rare combination, leading to significant clinical improvement.